J.L. Rodriguez-Bada

561 total citations
18 papers, 339 citations indexed

About

J.L. Rodriguez-Bada is a scholar working on Immunology and Allergy, Pharmacology and Dermatology. According to data from OpenAlex, J.L. Rodriguez-Bada has authored 18 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology and Allergy, 7 papers in Pharmacology and 7 papers in Dermatology. Recurrent topics in J.L. Rodriguez-Bada's work include Drug-Induced Adverse Reactions (7 papers), Asthma and respiratory diseases (6 papers) and Contact Dermatitis and Allergies (6 papers). J.L. Rodriguez-Bada is often cited by papers focused on Drug-Induced Adverse Reactions (7 papers), Asthma and respiratory diseases (6 papers) and Contact Dermatitis and Allergies (6 papers). J.L. Rodriguez-Bada collaborates with scholars based in Spain and Denmark. J.L. Rodriguez-Bada's co-authors include M. Blanca, Marı́a José Torres, Natalia Blanca‐López, Cristobalina Mayorga, G. Canto, Carmen Rondón, Paloma Campo, Tahía D. Fernández, Enrique Gómez Alcaide and Ezequiel Pérez‐Inestrosa and has published in prestigious journals such as Scientific Reports, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

J.L. Rodriguez-Bada

17 papers receiving 329 citations

Peers

J.L. Rodriguez-Bada
J.L. Rodriguez-Bada
Citations per year, relative to J.L. Rodriguez-Bada J.L. Rodriguez-Bada (= 1×) peers María Angeles Zambonino

Countries citing papers authored by J.L. Rodriguez-Bada

Since Specialization
Citations

This map shows the geographic impact of J.L. Rodriguez-Bada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Rodriguez-Bada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Rodriguez-Bada more than expected).

Fields of papers citing papers by J.L. Rodriguez-Bada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Rodriguez-Bada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Rodriguez-Bada. The network helps show where J.L. Rodriguez-Bada may publish in the future.

Co-authorship network of co-authors of J.L. Rodriguez-Bada

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Rodriguez-Bada. A scholar is included among the top collaborators of J.L. Rodriguez-Bada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Rodriguez-Bada. J.L. Rodriguez-Bada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Alonso, Ana, J.L. Rodriguez-Bada, María Elena Díaz Sánchez, et al.. (2025). Discovery and early validation of serum protein signatures in untreated multiple sclerosis patients: identification of candidate biomarkers for diagnosis and stratification. Frontiers in Immunology. 16. 1579045–1579045.
2.
Ciano-Petersen, Nicolás Lundahl, J.L. Rodriguez-Bada, Laura Leyva, et al.. (2023). Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations. Frontiers in Immunology. 14. 1242508–1242508. 2 indexed citations
3.
Ciano-Petersen, Nicolás Lundahl, J.L. Rodriguez-Bada, Roberto Álvarez‐Lafuente, et al.. (2021). Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment. Frontiers in Immunology. 12. 778204–778204. 6 indexed citations
4.
Hernáez, Bruno, María Jesús Pinto-Medel, Esther Calonge, et al.. (2020). Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation. Journal of Clinical Medicine. 9(4). 959–959. 5 indexed citations
5.
Pinto-Medel, María Jesús, J.L. Rodriguez-Bada, Pedro J. Serrano‐Castro, et al.. (2017). Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway. Scientific Reports. 7(1). 16585–16585. 6 indexed citations
6.
Pavı́a, José, María Jesús Pinto-Medel, J.L. Rodriguez-Bada, et al.. (2015). Development and Validation of an ELISA for Quantification of Soluble Ifn-β Receptor: Assessment in Multiple Sclerosis. Bioanalysis. 7(22). 2869–2880. 6 indexed citations
7.
Campo, Paloma, Mayte Villalba, Cristobalina Mayorga, et al.. (2013). Evaluation of in Vivo and in Vitro Responses to Nole e1 in Systemic and Local Allergic Rhinitis. Journal of Allergy and Clinical Immunology. 131(2). AB237–AB237. 2 indexed citations
8.
Blanca‐López, Natalia, et al.. (2012). Seasonal Local Allergic Rhinitis in Areas with High Exposure to Grass Pollen. Journal of Allergy and Clinical Immunology. 129(2). AB111–AB111. 4 indexed citations
9.
Rondón, Carmen, Paloma Campo, Natalia Blanca‐López, et al.. (2012). Prevalence and clinical relevance of local allergic rhinitis. Allergy. 67(10). 1282–1288. 124 indexed citations
10.
Blanca, M., Paloma Campo, Carmen Rondón, et al.. (2011). Response To Nasal Challenge With Lysine-aspirin In Subjects With Hypersensitivity Reactions To Nsaids With Respiratory Versus Cutaneous Involvement. Journal of Allergy and Clinical Immunology. 127(2). AB192–AB192. 2 indexed citations
11.
Campo, Paloma, C. Antúnez, Carmen Rondón, et al.. (2011). Positive Bronchial Challenges to D. Pteronyssinus in Asthmatic Subjects in Absence of Systemic Atopy. Journal of Allergy and Clinical Immunology. 127(2). AB6–AB6. 9 indexed citations
12.
Fernández, Tahía D., Marı́a José Torres, Natalia Blanca‐López, et al.. (2008). Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy. 64(2). 242–248. 128 indexed citations
13.
Cornejo‐García, J.A., Tahía D. Fernández, Cristobalina Mayorga, et al.. (2007). Cytokine and Transcription Factors Expression in Patients with Delayed Allergic Reactions to Drugs. Journal of Allergy and Clinical Immunology. 119(1). S272–S272. 1 indexed citations
14.
Torres, Marı́a José, Natalia Blanca‐López, E. Martín, et al.. (2007). Cross-reactivity Between Penicillins and Cephalosporins with the Same Side Chain: Amoxicillin and Cefadroxil. Journal of Allergy and Clinical Immunology. 119(1). S38–S38. 7 indexed citations
15.
Rondón, Carmen, Soledad López, R. R‐Pena, et al.. (2007). Positive Nasal Allergen Provocation Test and Nasal Specific-IgE to Grass Pollen in Patients with Idiopathic Rhinitis. Journal of Allergy and Clinical Immunology. 119(1). S314–S314. 4 indexed citations
16.
Rodriguez-Bada, J.L., María I. Montañez, Marı́a José Torres, et al.. (2006). Skin testing for immediate hypersensitivity to betalactams: comparison between two commercial kits. Allergy. 61(8). 947–951. 31 indexed citations
17.
Torres, Marı́a José, Cristobalina Mayorga, J.L. Rodriguez-Bada, et al.. (2005). Study of in vitro crossreactivity by determining specific IgE in patients with immediate adverse reactions to cephalosporins. Journal of Allergy and Clinical Immunology. 115(2). S32–S32. 1 indexed citations
18.
Padial, A., et al.. (2004). Role of the basophil activation test (BASOTEST) in the diagnosis of immediate allergic reactions to betalactams. Journal of Allergy and Clinical Immunology. 113(2). S69–S69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026